Cervical Squamous-Cell Carcinoma in a Case of Severe Beta Thalassemia/ Hemoglobin E Disease

Authors

  • Somchai Insiripong Department of Medicine, Saint Mary Hospital
  • Kulnaree Klunjaturus Department of Obstetrics and Gynecology, Saint Mary Hospital

Keywords:

squamous cell carcinoma, cervix, beta thalassemia/ hemoglobin E disease

Abstract

Hematologic malignancies and liver cancers are slightly more common among thalassemia patients than the general population. Here we report a case of cervical cancer in a patient with beta thalassemia/ hemoglobin E disease. A 66-year-old Thai woman presented with spotted vaginal bleeding for two days. Her underlying condition was severe beta thalassemia/ hemoglobin E disease and she needed regular blood transfusions every 3-4 months. Physical examination revealed marked pallor, typical thalassemic facies, and hepatomegaly. Pelvic examination showed an ulcerative mass of 2-3 cm at the cervix, involving the entire fornix and right pelvic wall, with both sides showing inguinal lymphadenopathy. Blood tests showed hematocrit 17.5%, ferritin 3876.1 ng/ml, and negativity for HBV, HCV and HIV. The average hematocrit was 19.2+2.3% before transfusion. Microscopic pathology of the cervical mass found non-keratinizing squamouscell carcinoma. She was clinically diagnosed with carcinoma of the cervix stage IIIB and underlying severe beta thalassemia/ Hb E disease, secondary hemosiderosis and mild transaminitis. After treatment by blood transfusion and chelating therapy, she was referred to the cancer center. Although an association between cervical cancer and severe thalassemia was not clearly established, the emergence of cancers in severe thalassemia cases should be kept under close surveillance because these patients survive longer with regular transfusion and chelation therapy

References

Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis E. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann NY Acad Sci 2005;1054:445-50.

Ricerca BM, Di Girolamo A, Rund D. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complication. Mediterr J Hematol Infect Dis 2009; 1(1): e2009028. doi: 10.4084/MJHID. 2009.028

Karimi M, Giti R. Malignancies in patients with beta thalassemia intermedia: a multicenter study in Iran. Pediatr Blood Cancer 2009;53:1064-7.

Chung WS, Lin CL, Lin CL, Kao CH. Thalassemia and risk of cancer: a population-based cohort study. J Epidemiol Community Health 2015;69:1066-70.

Mancuso A, Sciarrino E, Renda MC, Maggio A. A prospective study of hepatocellular carcinoma incidence in thalassemia. Hemoglobin 2006;30:11924.

Borgna-Pignatti C, Garani MC, Forni GL, Cappellini MD, Cassinerio E, Fidone C, et al. Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry. Br J Haematol 2014;167:121-6.

Zanella S, Garani MC, Borgna-Pignatti C. Malignancies and thalassemia: a review of the literature. Ann NY Acad Sci 2016;1368:140-8.

Casey PM, Long ME, Marnach M. Abnormal cervical appearance: what to do, when to worry? Mayo Clin Proc 2011;86:147-51.

Halawi R, Cappellini MD, Taher A. A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits. Am J Hematol 2017;92:414-6.

Thakkar JP, McCarthy BJ, Lee Villano J. Agespecific cancer incidence rates that continue to rise through the oldest age groups. Am J Med Sci 2014;348:65-70.

Maakaron LE, Cappellini MD, Graziadei G, Ayache JB, Taher AT. Hepatocellular carcinoma in hepatitisnegative patients with thalassemia intermedia: a closer look at the role of siderosis. Ann Hepatol 2013;12:142-6.

Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related disease and cancers. New Microbiol 2017;40:80-5.

Arabzadeh SAM, Alizadeh F, Tavakoli A, Mollaei H, Bokharaei-Salim F, Karimi G, et al. Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran. Blood Res 2017;52:50-4.

Al Ghwass ME, El Shafei SM, Mohamed WS, Mohamed BS. Seroprevalence of parvovirus B19 infection in patients with beta thalassemia major in Fayoum University Hospital. Egyptian Pediatr Assoc Gazette 2016;64:126-30.

Hayakawa H, Tara M, Niina K, Osame M. A clinical study of adult human parvovirus B19 infection. Interm Med 2002;41:295-9.

Oiwa H, Shimada T, Hashimoto M, Kawaguchi A, Ueda T, Sugiyama E, et al. Clinical findings in parvovirus B19 infection in 30 adult patients in Kyoto. Mod Rheumatol 2011;21:24-31.

Downloads

Published

2019-03-29

Issue

Section

Original Articles